AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • August 11th, 2021 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledAugust 11th, 2021 Company IndustryThis Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of May 10, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and 1315 Capital II, L.P., a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).
AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • May 20th, 2021 • 1315 Capital II, L.P. • Surgical & medical instruments & apparatus
Contract Type FiledMay 20th, 2021 Company IndustryThis Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of May 10, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and 1315 Capital II, L.P., a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).